• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

惊恐障碍患者的实验性情感症状

Experimental affective symptoms in panic disorder patients.

作者信息

Overbeek Thea, Schruers Koen, van Leeuwen Ine Docters, Klaassen Tineke, Griez Eric

机构信息

Academic Anxiety Center, Psychiatric Hospital Vijverdal, Maastricht, The Netherlands.

出版信息

Can J Psychiatry. 2005 Mar;50(3):175-8. doi: 10.1177/070674370505000307.

DOI:10.1177/070674370505000307
PMID:15830828
Abstract

OBJECTIVE

To date, carbon dioxide (CO2) challenge tests in panic disorder (PD) patients have focused on anxiety as the sole outcome measure. This study assesses a broader range of symptoms in patients with PD.

METHOD

We administered a gas mixture of 35% CO2 and 65% oxygen (O2) to 25 patients with PD. Nine patients met the criteria for a comorbid major depressive disorder (MDD), and 16 did not. We assessed not only subjects' symptoms of anxiety but also their symptoms of depression and aggression.

RESULTS

Baseline ratings did not differ across the 2 subgroups. Postchallenge ratings were higher for PD and MDD patients on all the assessed affective symptoms, except for specific panic symptoms.

CONCLUSION

These findings suggest that, in addition to anxiety, CO2 challenge induces depressive and aggressive symptoms, specifically in PD patients with comorbid depression.

摘要

目的

迄今为止,惊恐障碍(PD)患者的二氧化碳(CO₂)激发试验一直将焦虑作为唯一的结果指标。本研究评估了PD患者更广泛的症状范围。

方法

我们对25名PD患者给予了35% CO₂和65%氧气(O₂)的混合气体。9名患者符合共病重度抑郁症(MDD)的标准,16名患者不符合。我们不仅评估了受试者的焦虑症状,还评估了他们的抑郁和攻击症状。

结果

两个亚组的基线评分没有差异。除特定的惊恐症状外,PD和MDD患者在所有评估的情感症状方面激发后评分更高。

结论

这些发现表明,除焦虑外,CO₂激发还会诱发抑郁和攻击症状,特别是在伴有抑郁症的PD患者中。

相似文献

1
Experimental affective symptoms in panic disorder patients.惊恐障碍患者的实验性情感症状
Can J Psychiatry. 2005 Mar;50(3):175-8. doi: 10.1177/070674370505000307.
2
Acute panic inventory symptoms during CO(2) inhalation and room-air hyperventilation among panic disorder patients and normal controls.惊恐障碍患者和正常对照在吸入二氧化碳和室内空气过度通气期间的急性惊恐量表症状
Depress Anxiety. 2001;14(2):123-36. doi: 10.1002/da.1054.
3
Sensitivity to 35% carbon dioxide in patients with generalized anxiety disorder.广泛性焦虑障碍患者对35%二氧化碳的敏感性
J Clin Psychiatry. 1999 Jun;60(6):379-84. doi: 10.4088/jcp.v60n0606.
4
Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge.通过35%二氧化碳激发试验鉴别惊恐障碍和广泛性焦虑障碍
Am J Psychiatry. 1995 Jul;152(7):1081-3. doi: 10.1176/ajp.152.7.1081.
5
[Panic disorder and affective pathology (comorbidity aspects)].
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):9-13.
6
Cigarette smoking and 35% CO(2) induced panic in panic disorder patients.吸烟和 35% CO(2) 可诱发惊恐障碍患者惊恐发作。
J Affect Disord. 2010 Jul;124(1-2):215-8. doi: 10.1016/j.jad.2009.10.012. Epub 2009 Nov 6.
7
Response to 5% carbon dioxide in children and adolescents: relationship to panic disorder in parents and anxiety disorders in subjects.儿童和青少年对5%二氧化碳的反应:与父母惊恐障碍及受试者焦虑症的关系。
Arch Gen Psychiatry. 2005 Jan;62(1):73-80. doi: 10.1001/archpsyc.62.1.73.
8
Comorbid depressive disorder increases vulnerability to the 35% carbon dioxide (CO2) challenge in panic disorder patients.
J Affect Disord. 1998 Jun;49(3):195-201. doi: 10.1016/s0165-0327(98)00023-8.
9
Carbon dioxide/oxygen challenge test in panic disorder.惊恐障碍中的二氧化碳/氧气激发试验。
Psychiatry Res. 1994 May;52(2):159-71. doi: 10.1016/0165-1781(94)90085-x.
10
Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges.惊恐障碍和强迫症患者对35%二氧化碳激发试验的实验室反应。
Am J Psychiatry. 1995 Jan;152(1):85-9. doi: 10.1176/ajp.152.1.85.

引用本文的文献

1
Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial.艾司西酞普兰预防创伤后应激障碍:一项初步随机对照试验。
BMC Psychiatry. 2015 Feb 19;15:24. doi: 10.1186/s12888-015-0391-3.